Publications

Case report of Aurantimonas altamirensis bloodstream infection. by Mendes RE, Denys GA, Fritsche TR and Jones RN published in J. Clin. Microbiol. 2009; 47 (2): 514-515

Doripenem (DOR) Activity Against a Global Collection of Enterobacteriaceae (ENT), Including Isolates Resistant (R) to Extended-Spectrum Agents, Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Emergence of bla_CTX-M Among Enterobacteriaceae (ENT) Isolates in USA Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Castanheira M, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Polymyxin-Resistant (PR) KPC-3-Producing K. pneumoniae (KPN) in USA and Israel: Challenging Therapies and Molecular Typing Methods, Lead author: Castanheira M, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Increasing Prevalence of KPC-Producers as an Emerging Resistance Mechanism Among Carbapenem Non-Susceptible Isolates: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Castanheira M, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Activity of Daptomycin and Comparators Tested Against S. aureus from 20 USA Hospitals in 2005-2008: Evaluation of Potency Trends, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Activity of Oritavancin Tested Against Contemporary Gram-Positive Pathogens Submitted to a Global Surveillance Program (2008), Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Activity of Telavancin Tested Against Contemporary Gram-Positive Pathogens: Results from an International Surveillance Program (2007), Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Ceftobiprole Activity Tested Against North American Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp. in 2005-2007, Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Ceftaroline Activity Tested Against Organisms Causing Skin and Skin Structure Infections (SSSI) Isolated in USA and European Medical Centers in 2008, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

In Vitro Activity of Ceftaroline (CPT) in Combination Against Extended-Spectrum ß-lactamase (ESBL) Producing Gram-Negative (GN) Bacteria, Lead author: Vidaillac, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

In Vitro Activity of Dalbavancin Tested Against a Worldwide Collection of 81,677 Gram-Positive Bacterial Isolates, Lead author: Biedenbach DJ, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Activity of Omiganan, a Novel Peptide, Tested Against Contemporary Gram-Negative Pathogens: Results from an International Surveillance Program (2008), Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Activity of Ceftaroline (CPT) Tested Against Contemporary (2008) Bacteria Isolated from Community-Acquired Respiratory Tract Infections (CARTI), Including Oxacillin-Resistant S. aureus (MRSA), Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

The Changing Face of Oxacillin-Resistant Staphylococcus aureus in the Asia-Pacific Region: A SENTRY Report, 1998 -2007, Lead author: Turnidge JD, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Evaluation of Vancomycin (VAN) Potency Trends (&quotCreep&quot) Against Methicillin-Resistant S. aureus Collected in Nine United States Hospitals Over Five Years (2002- 2006), Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Susceptibility of Clinical Strains of KPC-Producing and CTX-M-Producing Enterobacteriaceae: A Global Analysis, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Acquired Carbapenem Hydrolyzing ß-Lactamases Among Clinical Strains of Acinetobacter spp. from Latin America: Report from the SENTRY Antimicrobial Program, Lead author: Gales AC, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Rapid Emergence and Spread of Acinetobacter spp. (ASP) Producing Carbapenem-Hydrolyzing Oxacillinases (CHCDß): Report from the SENTRY Program, Lead author: Mendes RE, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Outbreak Caused by a Clone of OXA-23- or OXA-58-Producing Acinetobacter baumannii (ACB) in a Rome Hospital: First Outbreak of bla_OXA-23-Carrying ACB in Italy, Lead author: Mendes RE, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Coproduction of OXA-58 and IMP-1 Carbapenemases in an Acinetobacter lwoffii (AL), Lead author: Mendes RE, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

In Vitro Activity of Tigecycline Tested against Acinetobacter spp. Producing Carbapenem-Hydrolyzing Oxacillinases: a Global Study of 320 Strains, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

An Extended Aminoglycoside Resistance Profile in Isolates of Enterobacteriaceae from the Sentry Surveillance Program in the Asia-Pacific Region, 2007, Lead author: Bell JM, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Enterobacter Species as a Major Reservoir for Extended-Spectrum ß-lactamase Encoding and Related Genes in the Sentry Asia-Pacific Region 2006, Lead author: Bell JM, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Comparison of Broth Microdilution and Etest Method Results when Testing Vancomycin (VAN) and Daptomycin (DAP) Against Methicillin-Resistant S. aureus (MRSA) from 9 USA Hospitals, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Evaluation of the Accuracy of the Etest Macromethod for Detection of Heterogeneous Vancomycin-Intermediate S. aureus (hVISA) Strains, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

A Multi-Site Study of an 18-24h Susceptibility System to the CLSI Microdilution Method for Gram-Negative and Gram-Positive Organisms vs. Doxycycline, Lead author: Killian SB, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

A Multi-Site Study of an 18-24h Susceptibility System to the CLSI Microdilution Method for Acinetobacter spp., Pseudomonas spp. and Pseudomonas aeruginosa vs. Colistin(COL) and Polymixin B (POL), Lead author: Holliday, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Proposed MIC Quality Control Ranges for CEM-101 Using the CLSI Multi-Laboratory M23-A2 Study Design, Lead author: Rhomberg PR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Tigecycline In Vitro Susceptibility Test Accuracy Using Three Methods and USA-FDA Interpretive Criteria When Testing Japanese Clinical Isolates (2007), Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

TR-700, a Novel Oxazolidinone, Tested Against Linezolid-Resistant Gram-positive Species with Well-Characterized Resistance Mechanisms, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Novel Nanoemulsion Antimicrobials Tested Against Nine Gram-Positive Species, Lead author: Sutcliffe, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Activity of Nanoemulsions Tested Against Seven Gram-Negative Species, Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101 Activity Against 331 Respiratory Tract Pathogens Including Multidrug-Resistant Pneumococcal Serogroup 19A (MDR-19A) Isolates, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: Activity Against Enterococci, Uncommon Gram-positive Pathogens, N. gonorrhoeae and Anaerobes, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: Potential Application Against Species Causing Enteritis/Gastroenteritis, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: PAE, Bactericidal Activity and Combinations, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: Single Step, Selection by Passaging and Inducible Resistances, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Assessment of CEM-101 Susceptibility Testing Conditions and Optimization of Disk Diffusion Methods, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Proposed Quality Control (QC) Parameters for Disk Diffusion (DD) Tests with Anidulafungin, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Voriconazole Activity Against Aspergillus spp: Eight Years of Global Surveillance, Lead author: Diekema DJ, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Activity of Anidulafungin and Other Antifungal Agents: Results from an International Fungal Surveillance Program (2006-2007), Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Activity of Daptomycin Tested against Gram-positive Clinical Strains with Acquired Resistance to Linezolid, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Activity of Daptomycin and Comparator Agents Tested Against Gram-positive Organisms from Hong Kong, Indonesia, Philippines, Singapore and Thailand, Lead author: Turnidge JD, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Daptomycin Activity Tested Against Gram-positive Bacteria Isolated from Medical Centers Located in China (2006), Lead author: Chen, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Multicenter Evaluation of Tigecycline Activity in India: Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Jones RN, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Multicenter Evaluation of Tigecycline: An in Vitro Update Against Clinical Pathogens from Japan (2006-2007), Lead author: Kohno, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Dalbavancin Tested Against Staphylococcus spp. and Streptococcus spp. Isolates collected from Five European Counties: Comprehensive DECIDE Program Results (2007), Lead author: Biedenbach DJ, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Activity of Tigecycline against Clinical Pathogens Collected in Indonesia (2006), Lead author: Turnidge JD, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Tigecycline Activity against Isolates from Medical Centers Located in China, Hong Kong and Taiwan (2006): A SENTRY Antimicrobial Surveillance Program Report, Lead author: Chen, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia